Zanosar
ZANOSAR (Streptozocin Sterile Powder)
Approved
Approval ID
15d161ed-9e7b-4c92-ba45-0556d2423e67
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 24, 2023
Manufacturers
FDA
Teva Parenteral Medicines, Inc.
DUNS: 794362533
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
streptozocin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0703-4636
Application NumberNDA050577
Product Classification
M
Marketing Category
C73594
G
Generic Name
streptozocin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 29, 2023
FDA Product Classification
INGREDIENTS (3)
STREPTOZOCINActive
Quantity: 100 mg in 1 mL
Code: 5W494URQ81
Classification: ACTIB
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT